Lannett Company - News Releases http://lannett.investorroom.com/ Lannett is a US-based pharmaceuticals company manufacturing and/or commercially marketing over 100 generic pharmaceutical products. Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine http://lannett.investorroom.com/2018-11-12-Lannett-Enters-Into-Agreement-With-Amneal-Pharmaceuticals-For-Levothyroxine --Lannett Locks in $50 Million of Gross Profit for 16-Week Period-- Mon, 12 Nov 2018 06:54:00 -0500 http://lannett.investorroom.com/2018-11-12-Lannett-Enters-Into-Agreement-With-Amneal-Pharmaceuticals-For-Levothyroxine Lannett Announces Fiscal 2019 First-Quarter Financial Results; Re-Affirms Adjusted Guidance For Fiscal 2019 http://lannett.investorroom.com/2018-11-07-Lannett-Announces-Fiscal-2019-First-Quarter-Financial-Results-Re-Affirms-Adjusted-Guidance-For-Fiscal-2019 - Fiscal 2019 First Quarter Net Sales and Adjusted Net Income Ahead of Expectations Wed, 07 Nov 2018 16:16:00 -0500 http://lannett.investorroom.com/2018-11-07-Lannett-Announces-Fiscal-2019-First-Quarter-Financial-Results-Re-Affirms-Adjusted-Guidance-For-Fiscal-2019 Supplemental Information to Fiscal 2019 First Quarter Financial Results http://lannett.investorroom.com/2018-11-07-Supplemental-FY-2019-First-Quarter Product Launches, Cost Savings Wed, 07 Nov 2018 11:46:00 -0500 http://lannett.investorroom.com/2018-11-07-Supplemental-FY-2019-First-Quarter Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products http://lannett.investorroom.com/2018-11-06-Lannett-Announces-Expanded-Agreement-With-Strategic-Alliance-Partner-HEC-Pharm-Group-To-Distribute-Two-FDA-Approved-Products --Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019-- Tue, 06 Nov 2018 06:54:00 -0500 http://lannett.investorroom.com/2018-11-06-Lannett-Announces-Expanded-Agreement-With-Strategic-Alliance-Partner-HEC-Pharm-Group-To-Distribute-Two-FDA-Approved-Products Lannett Enters Into Distribution Agreement For Vardenafil Hydrochloride Tablets http://lannett.investorroom.com/2018-11-01-Lannett-Enters-Into-Distribution-Agreement-For-Vardenafil-Hydrochloride-Tablets --Launch Commenced; First-Time Generic Launch of Levitra®-- Thu, 01 Nov 2018 06:46:00 -0400 http://lannett.investorroom.com/2018-11-01-Lannett-Enters-Into-Distribution-Agreement-For-Vardenafil-Hydrochloride-Tablets Lannett To Report Fiscal 2019 First-Quarter Financial Results, Host Conference Call On Wednesday, November 7 http://lannett.investorroom.com/2018-11-01-Lannett-To-Report-Fiscal-2019-First-Quarter-Financial-Results-Host-Conference-Call-On-Wednesday-November-7 Thu, 01 Nov 2018 06:31:00 -0400 http://lannett.investorroom.com/2018-11-01-Lannett-To-Report-Fiscal-2019-First-Quarter-Financial-Results-Host-Conference-Call-On-Wednesday-November-7 Lannett And Adare Enter Into Distribution Agreement For Dexmethylphenidate Hydrochloride Extended Release Capsules http://lannett.investorroom.com/2018-10-22-Lannett-And-Adare-Enter-Into-Distribution-Agreement-For-Dexmethylphenidate-Hydrochloride-Extended-Release-Capsules Mon, 22 Oct 2018 06:52:00 -0400 http://lannett.investorroom.com/2018-10-22-Lannett-And-Adare-Enter-Into-Distribution-Agreement-For-Dexmethylphenidate-Hydrochloride-Extended-Release-Capsules Lannett Engages Advisors To Explore And Evaluate Debt And Capital Structure Alternatives http://lannett.investorroom.com/2018-10-08-Lannett-Engages-Advisors-To-Explore-And-Evaluate-Debt-And-Capital-Structure-Alternatives Mon, 08 Oct 2018 09:31:00 -0400 http://lannett.investorroom.com/2018-10-08-Lannett-Engages-Advisors-To-Explore-And-Evaluate-Debt-And-Capital-Structure-Alternatives Lannett Launches Five New Products In Fiscal 2019 First Quarter http://lannett.investorroom.com/2018-10-01-Lannett-Launches-Five-New-Products-In-Fiscal-2019-First-Quarter Mon, 01 Oct 2018 06:52:00 -0400 http://lannett.investorroom.com/2018-10-01-Lannett-Launches-Five-New-Products-In-Fiscal-2019-First-Quarter Lannett Announces Fiscal 2018 Fourth-Quarter and Full-Year Financial Results; Provides Guidance for Fiscal 2019 http://lannett.investorroom.com/2018-08-28-Lannett-Announces-Fiscal-2018-Fourth-Quarter-And-Full-Year-Financial-Results-Provides-Guidance-For-Fiscal-2019 Tue, 28 Aug 2018 16:15:00 -0400 http://lannett.investorroom.com/2018-08-28-Lannett-Announces-Fiscal-2018-Fourth-Quarter-And-Full-Year-Financial-Results-Provides-Guidance-For-Fiscal-2019